| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.2 | 4e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-07 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.2 | 8e-07 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-06 |